1,3-Bis(4-tert-butylbenzyl)-4,5-dihydroimidazolium chloride monohydrate
dc.authorid | Arslan, Hakan/0000-0003-0046-9442 | |
dc.authorid | Özdemir, İsmail/0000-0001-6325-0216 | |
dc.authorid | Yaşar, Sedat/0000-0001-7285-2761 | |
dc.authorid | Cetinkaya, Bekir/0000-0002-4551-8650 | |
dc.authorwosid | Arslan, Hakan/B-1081-2008 | |
dc.authorwosid | Özdemir, İsmail/ABI-5192-2020 | |
dc.authorwosid | Yaşar, Sedat/ABG-8356-2020 | |
dc.contributor.author | Arslan, Hakan | |
dc.contributor.author | VanDerveer, Don | |
dc.contributor.author | Yasar, Sedat | |
dc.contributor.author | Ozdemir, Ismail | |
dc.contributor.author | Cetinkaya, Bekir | |
dc.date.accessioned | 2024-08-04T20:31:08Z | |
dc.date.available | 2024-08-04T20:31:08Z | |
dc.date.issued | 2009 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | In the title compound, C25H35N2+center dot Cl-center dot H2O,the imidazolidine ring adopts a twisted conformation, with a pseudo-twofold axis passing through the N-C-N carbon and the opposite C-C bond. The N-C-N fragment of the imidazolidine ring shows some degree of both double- and single-bond character due to partial electron delocalization. One of the tert-butyl groups is disordered over two conformations with occupancies of 0.714 (8) and 0.286 (8). In the crystal, O-H center dot center dot center dot Cl and C-H center dot center dot center dot O hydrogen bonds help to establish the packing. | en_US |
dc.description.sponsorship | Technological and Scientific Research Council of Turkey TUBITAK-CNRS [TBAG-U/181 (106 T716)]; Inonu University Research Fund (BAP) [2008-Gudumlu3] | en_US |
dc.description.sponsorship | We thank the Technological and Scientific Research Council of Turkey TUBITAK-CNRS [TBAG-U/181 (106 T716)] and Inonu University Research Fund (BAP: 2008-Gudumlu3) for financial support. | en_US |
dc.identifier.doi | 10.1107/S1600536809000452 | |
dc.identifier.endpage | U2062 | en_US |
dc.identifier.issn | 2056-9890 | |
dc.identifier.pmid | 21581919 | en_US |
dc.identifier.scopus | 2-s2.0-60349090362 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | O310 | en_US |
dc.identifier.uri | https://doi.org/10.1107/S1600536809000452 | |
dc.identifier.uri | https://hdl.handle.net/11616/94751 | |
dc.identifier.volume | 65 | en_US |
dc.identifier.wos | WOS:000263040700183 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Int Union Crystallography | en_US |
dc.relation.ispartof | Acta Crystallographica Section E-Crystallographic Communications | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Ligands | en_US |
dc.title | 1,3-Bis(4-tert-butylbenzyl)-4,5-dihydroimidazolium chloride monohydrate | en_US |
dc.type | Article | en_US |